Contrast-enhanced MR imaging in neuroimaging

Bum soo Kim, Juan E. Gutierrez

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


MR imaging without and with gadolinium-based contrast agents (GBCAs) is an important imaging tool for defining normal anatomy and characteristics of lesions. GBCAs have been used in contrast-enhanced MR imaging in defining and characterizing lesions of the central nervous system for more than 20 years. The combination of unenhanced and GBCA-enhanced MR imaging is the clinical gold standard for the noninvasive detection and delineation of most intracranial and spinal lesions. MR imaging has a high predictive value that rules out neoplasm and most inflammatory and demyelinating processes of the central nervous system.

Original languageEnglish (US)
Pages (from-to)649-685
Number of pages37
JournalMagnetic Resonance Imaging Clinics of North America
Issue number4
StatePublished - Nov 2012


  • Contrast-enhanced MR imaging (CE MR imaging)
  • Diffusion-weighted imaging (DWI)
  • Gadolinium-based contrast agents (GBCAs)
  • Lineal agent
  • MR spectroscopy (MRS)
  • Microcyclic agent
  • Perfusion MR imaging (pMR imaging)
  • Susceptibility-weighted imaging (SWI)

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Contrast-enhanced MR imaging in neuroimaging'. Together they form a unique fingerprint.

Cite this